SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-087326
Filing Date
2024-04-04
Accepted
2024-04-04 16:52:02
Documents
13
Period of Report
2024-03-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d819564d8k.htm   iXBRL 8-K 23952
  Complete submission text file 0001193125-24-087326.txt   142211

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA crnx-20240329.xsd EX-101.SCH 2856
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE crnx-20240329_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crnx-20240329_pre.xml EX-101.PRE 10816
16 EXTRACTED XBRL INSTANCE DOCUMENT d819564d8k_htm.xml XML 3510
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 24823738
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)